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Methylation of a conserved lysine in C-terminal domain of the molecular chaperone Hsp90
was shown previously to affect its in vivo function. However, the underlying mechanism
remained elusive. Through a combined experimental and computational approach, this study
shows that this site is very sensitive to sidechain modifications and crucial for Hsp90 activity
in vitro and in vivo. Our results demonstrate that this particular lysine serves as a switch point
for the regulation of Hsp90 functions by influencing its conformational cycle, ATPase activity,
co-chaperone regulation, and client activation of yeast and human Hsp90. Incorporation of
the methylated lysine via genetic code expansion specifically shows that upon modification,
the conformational cycle of Hsp90 is altered. Molecular dynamics simulations including the
methylated lysine suggest specific conformational changes that are propagated through
Hsp90. Thus, methylation of the C-terminal lysine allows a precise allosteric tuning of Hsp90
activity via long distances.
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Hsp90 is a highly conserved molecular chaperone in thecytoplasm of eukaryotic cells. It is responsible for thefolding, activation, and maturation of several hundred
client proteins1,2. The main classes of Hsp90 clients include
kinases3, transcription factors4,5, and E3-ligases among others6–8.
Many of these clients play a key role in diseases like cancer, cystic
fibrosis, and Alzheimer’s, making Hsp90 a promising target for
therapeutic approaches9–11.
Hsp90 is a dimeric protein, in which each protomer consists of
three domains: an N-terminal domain (NTD) containing the
ATP binding pocket, a middle domain important for client and
co-chaperone interaction, and a C-terminal dimerization domain
(CTD)12–14. The dimeric protein traverses from an N-terminally
open state to a closed and twisted conformation, in which the
NTDs and middle domains are associated as a prerequisite
for ATP hydrolysis15–18. Subsequently, Hsp90 regains its open,
V-shaped conformation. This ATPase cycle can be modulated by
a cohort of Hsp90 co-chaperones, which are only found in
eukaryotes. Some co-chaperones accelerate the Hsp90 cycle,
whereas others have a decelerating effect19–21. A further impor-
tant regulatory element of the Hsp90 cycle are post-translational
modifications (PTMs)22. PTMs are covalent modifications of
specific amino acid side chains that regulate activity, localization
or interactions23–25. Hsp90 is strongly affected by different PTMs,
e.g. phosphorylation26–28, acetylation29–31, nitrosylation32,33,
ubiquitination34, SUMOylation35,36, nitration37, glycosylation38,
and methylation39,40. These PTMs in Hsp90 are distributed
throughout the protein23. Some positions targeted by PTMs have
been shown to represent conformational switch points where a
small modification can decisively change the properties of Hsp90
in an allosteric manner23,28,33.
Methylation of a lysine residue in human Hsp90 by the
methyltransferase Smyd2 is a recently discovered PTM39,40.
The methylation site is located at positions K615 (Hsp90α)
and K607 (Hsp90β) in the CTD of Hsp90, and the methyl
moiety can be removed by the lysine demethylase LSD139.
Whether Smyd2 methylates both Hsp90 protomers symme-
trically is not known. The mono-methylation at this position
enhances the interaction of Hsp90 with the muscle protein titin,
leading to a stabilization of the I-band in skeletal as well
as cardiac muscle cells40,41. Despite the importance of the
methylation of Hsp90 for muscle stability, the mechanistic
effect of this modification on Hsp90 has remained elusive. Here,
we set out to investigate how variations at this position affect
the structure and function of yeast and human Hsp90 protein,
complemented by atomistic MD simulations. We discovered
that the methylation position is a switch point in Hsp90 con-
served from yeast to man and specifically modulates conserved
Hsp90 functions.
Results
The methylation position is conserved in the Hsp90 family.
Lysine methylation is a PTM of Hsp90 that has been described for
both human homologues39,40. The respective lysine residue is part
of a highly conserved amino acid sequence in eukaryotic Hsp90s
(Fig. 1a). In fact, this amino acid stretch (ANMERIMKAQALRD) is
the longest conserved sequence in the CTD. This supports the
importance of the region and the methylation position, as the sites
of other PTMs are not generally conserved23,28. In the crystal
structure of yeast Hsp9015, the ANMERIMKAQALRD region is
located at the intersection between a helix and an unstructured/
unresolved loop. For human Hsp90ß42, the surrounding of K607
is similar with the difference that the region is fully resolved,
showing an extended helix compared with the yeast homologue
(Fig. 1b).
Lysine mutations affect the Hsp90 ATPase. We wondered
whether the position of the lysine in Hsp90 targeted by methy-
lation is in general sensitive to changes in its amino acid side-
chain. We therefore replaced the respective lysine, K594 in yeast
Hsp90 (yHsp90), and K607 in human Hsp90β (hHsp90β), by four
different amino acids: alanine (neutral), isoleucine (hydrophobic),
glutamic acid (negative charge), or arginine (positive charge).
These variants were expressed in E. coli and purified. The mutant
proteins were stable and adopted wild type (WT)-like secondary
structures (Supplementary Fig. 1A, B). Since the mutated site is
close to the C-terminal dimerization surface, we first tested the
influence of the introduced mutations on the dimerization
properties43. The KD values determined are in the same range
(30–60 nM for yHsp90 and 6–13 nM for hHsp90β). Thus, the
mutants do not exhibit significant changes in dimer formation
compared with the WT (Supplementary Fig. 2A, B). Although the
mutated site is far away from the ATPase site in the NTD, we
tested whether the intrinsic ATPase activity of Hsp90 is altered
and observed pronounced effects. For all yHsp90 mutants, except
the replacement of lysine by arginine (K594R), the ATP turnover
is impaired (Fig. 1c). The negative charge substitution showed the
strongest effect (about 70% reduction), while the neutral and
hydrophobic substitutions caused a slighter decrease. The same
effects were obtained for the mutations in hHsp90β (Fig. 1d):
again, the replacement of lysine with an arginine had no sig-
nificant effect on the ATPase activity, whereas the neutral,
hydrophobic, and negative charge substitutions caused reductions
in the ATP turnover. The most severe defects were again observed
for the negatively charged replacement mutant K607E. To
probe whether ATP binding was also influenced by the sub-
stitutions, ATPase activity assays were performed with varying
concentrations of ATP (Supplementary Fig. 3A, B). The KM
values of the different mutants were comparable to those of the
WT, showing that the affinity for ATP is not affected by the
substitutions.
These results indicate three important features: first, the ATP
turnover can be regulated by changes at the position of the lysine
in the CTD, ~70 Å away from the active site, and hence this
residue is an allosteric regulation point. Second, a positive charge
at this position is crucial for a WT-like ATPase activity, as
arginine can replace lysine without affecting the ATP turnover.
Third, the allosteric regulation point is conserved, as the human
and the yeast homologues react identically to the amino acid
changes at this position.
Lysine mutations affect co-chaperone interaction. Some co-
chaperones bind to specific Hsp90 conformations and are thus
excellent tools for the analysis of the Hsp90 cycle20,44. As the co-
chaperone Aha1 accelerates the Hsp90 ATPase activity45 by
binding to the M- and N-domains of Hsp9046–48, and promoting
the formation of the closed state47,49,50, we used Aha1 as a sensor
for this conformational transition in the variants studied and
performed ATPase activity assays with increasing Aha1 con-
centrations. In yHsp90, for the mutant K594R, the presence of
Aha1 led to a similar activation as observed for the WT protein.
K594A and K594I, were in contrast less activated, and K594E did
not show any stimulation, even at the highest employed Aha1
concentration (Fig. 2a). For the respective variants of human
Hsp90, a conserved pattern of effects concerning the ability to
stimulate the ATPase by Aha1 was observed: K607R and hHsp90β-
WT were stimulated comparably, whereas K607A and K607I were
only accelerated by ~20% of the WT levels and, again, the K607E
mutant was not activated by Aha1 (Fig. 2c). To test whether
the yeast and human proteins are still able to bind Aha1, we
performed analytical ultracentrifugation (aUC) experiments with
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FAM-labelled Aha1 (Fig. 2b, d). Complex formation by binding of
Aha1 to Hsp90 results in a shift of the sedimentation coefficients
from 3 to 8 s. We observed complex formation for all yHsp90
variants, with WT and K594R showing identical sedimentation
profiles (Fig. 2b). For the interaction of Aha1 with K594A, K594I,
and K594E, lower S values were observed for the complexes. This
can be explained by a different shape of the complex, possibly a
more open conformation. We also obtained similar results for the
human proteins (Fig. 2d). K607R showed an identical sedimenta-
tion profile as the WT protein, while all other mutants exhibited a
decreased interaction with Aha1 and hence a less pronounced shift
in the S values. Importantly, the binding sites for Aha1 are in the
M- and N-domains of Hsp9046–48. Taken together, these results
suggest that alterations at this conserved lysine in the CTD lead to
changes in the Aha1-supported conformational rearrangements in
the M- and N-domains of Hsp90. Interestingly, while Aha1 is still
able to bind to yeast and human Hsp90, no stimulation of the
ATPase activity of the K594E and K607E mutants could be
detected. Hence, the closing defect of these mutants cannot be
rescued by Aha1.
We next probed the influence of the inhibitory co-chaperones
p23/Sba1 and Sti1 on the yeast mutants19,51,52. The human
variants were omitted from this experiment as the intrinsic ATP
turnover of the human variants and the inhibitory effect of p23
and Sti1 is quite low, which makes the detection of a further
decrease difficult. Recent studies however showed that some
newly discovered co-chaperones are impacting Hsp90’s ATPase
activity to a higher degree and might therefore be a viable sensor
for future studies21,22. Sti1 binds to Hsp90 in its open
conformation and prevents further rearrangements towards
the closed state, thereby inhibiting the ATP turnover of the
protein19,53. For all yeast variants, we observed a WT-like
inhibitory effect of this co-chaperone, indicating that neither Sti1







































































Fig. 1 Position of the modified lysine residue and ATPase of Hsp90 variants. a Sequence alignment of various cytosolic Hsp90s. The alignment highlights
the methylation position, which is embedded in a highly conserved amino acid stretch. b Crystal structure of yeast Hsp90 (left)15 and human Hsp90 (right)42
in which the conserved lysine residue (K594/K607) (red) is located in a helix. The intrinsic ATP turnover of yeast Hsp90 (c) and human Hsp90ß (d) was
determined using an ATP regenerating assay. The ATPase activity of the human homologue was already shown to be significantly lower compared with the
yeast version and is herein confirmed. All replacement mutants except for the substitutions from lysine to arginine resulted in an impairment of the ATP
turnover. The WT is shown in black/dark grey, the alanine substitution in light blue, the arginine substitution in dark blue, the glutamate substitution in red,
and the isoleucine substitution in cyan dark. The colour code is used for the mutations throughout the manuscript. The error bars for the turnover rates
represent s.d. from three independent measurements (n= 3). Statistical significance was assessed using a two-sample t-test and a level of significance of
0.05 (*), 0.01 (**), and 0.001 (***). Source data are provided as a Source Data file.
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conformation is diminished by the substitution of the lysine
residue (Supplementary Fig. 4).
p23/Sba1 binds to the NTD of Hsp90 in its closed
conformation15,54–56, and can thus be used as a sensor to
specifically probe the ability of the mutants to reach the closed-2
state50,56. We therefore analyzed the effect of Sba1 on the
inhibition of the Hsp90 ATPase activity51,57 (Fig. 2e), and
determined the binding of Sba1 by aUC (Fig. 2f). Binding
of labelled Sba1 to Hsp90 leads to a shift in the S value from 3 to
8 s. All yeast mutants showed this shift although to different
extents. K594R and the WT protein bound equally well to Sba1
and inhibited the ATPase activity of Hsp90 to the same level,
whereas binding and inhibition of the neutral substitutions
K594A and K594I were slightly impaired. K594E instead showed
the lowest complex formation and no inhibition of the ATPase
activity. Thus, alteration of the conserved lysine residue in the
CTD affects the ability of Hsp90 to adopt a closed conformation,
which can be bound by p23/Sba1.
In vivo effects of mutations in the methylated site. To test
whether the variants affect the function of Hsp90 in vivo, we
introduced them as the sole source of Hsp90 in S. cerevisiae.
It was previously described that also the human isoforms can
substitute the essential function of Hsp90 in yeast and confer
viability58. We observed that all yeast and human mutants, except
for human K607E, which had already shown the most severe
in vitro defects, support yeast viability (Fig. 3a). Since human
Hsp90 cannot replace yeast Hsp82 efficiently58, the presence of
a mutation that affects Hsp90 function may therefore be
more severe for the human protein, especially in the yeast via-
bility assay. At the optimal growth temperature of 30 °C for
S. cerevisiae, the negative charge mutant K594E grows slower as
compared with the WT and the other replacement mutants
(Fig. 3b). When the mutants were shifted to higher (37 °C) or
lower (25 °C) temperatures, K594E differed even more in its
growth behaviour. The human variants reacted more sensitive to
a change in temperature, independently of the direction of the
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Fig. 2 Co-chaperone actions are influenced by the modifications. a, c ATP turnover of the WT and the different mutants in the presence of the co-
chaperone Aha1. b, d The binding of the different Hsp90 constructs to Aha1 was analyzed by analytical ultracentrifugation. dc/dt plots are shown for Aha1-
FAM (purple) and the mixtures of Aha1-FAM with the indicated Hsp90 constructs. e Normalized ATPase activity of the WT and the mutants in the
presence of the inhibitory protein p23/Sba1. f The binding of the different Hsp90 mutants to p23/Sba1 was analyzed by analytical ultracentrifugation. dc/dt
plots are shown for p23/Sba1-Atto488 (purple) and its mixtures with the indicated mutants.
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shift. At these temperatures, the growth of the hHsp90ß-WT was
already impaired compared with the yeast WT. The neutral
substitution mutants, K607A and K607I, displayed even greater
growth deficiencies. Only K607R showed a growth rate similar to
its corresponding WT (Fig. 3b).
We next tested the effect of the Hsp90 inhibitor radicicol
towards the yeast mutants, as it is known from previous studies
that changes in the M- and C-domains can lead to differences in
radicicol sensitivity28. Radicicol competes with ATP for binding
to the Hsp90 NTD59,60. It affects both the yeast and the human
Hsp90 homologues58,61. Hence, all cells were grown in the
presence of different radicicol concentrations and subsequently
spotted on agar plates (Fig. 3c). For the yeast proteins, only
K594R showed a WT-like sensitivity, while the alanine and
isoleucine mutants exhibited an increased sensitivity for the
inhibitor. Yeast strains carrying the K594E mutant were barely
viable in the presence of radicicol. The same observation was
made for the yeast strains carrying the human Hsp90 homologues
(Fig. 3c, lower panel; for quantification see Supplementary Fig. 5).
There was only marginal growth for any strain, even the one
carrying Hsp90ß-WT. Taken together, these results show that
lysine 594/607 is important for the in vivo function of Hsp90
in yeast.
Changes in the methylation position affect client processing.
The results described so far demonstrate that changes at the
position of the methylated lysine allosterically modulate Hsp90
in vitro and in vivo. We next addressed how changes at
this position affect client protein activation in S. cerevisiae
using selected client proteins for which well-established assays
exist28,62,63.
Several components of the endogenous yeast DNA repair
mechanism were previously described as Hsp90-dependent64–66.
Exposure of yeast cells to different dosages of UV-light leads to
pyrimidine dimer formation, and in consequence to induction of
the Hsp90 dependent nucleotide excision repair67. At a light
dosage of 40 J/m2, only a slight growth deficiency was observed
for the yeast carrying the K594E mutant, while the other mutants
showed WT-like behaviour (Fig. 4a). At 80 J/m2, the differences
were more pronounced: K594E could not recover from the
applied stress and the yeast carrying the alanine and isoleucine
mutants were more affected than their corresponding WTs or the
arginine replacement.
v-Src kinase is a strictly Hsp90-dependent client. When
expressed in yeast in its active form, v-Src leads to hyper-
phosphorylation and subsequent cell death68. This effect
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Fig. 3 Influence of lysine variants in vivo. a A FOA-shuffling approach was used to introduce the Hsp90 variants as the sole source of Hsp90 in the yeast
S. cerevisiae. All mutants, except those carrying the empty vector and the human Hsp90ß mutant K607E were viable. b Drop assays to observe growth
differences between the different strains. All shuffled yeast strains grew similarly at 30 °C but started showing growth deficiencies at lower and higher
temperatures. c Hsp90 mutants were tested towards their sensitivity against various concentrations of the inhibitor radicicol. Source data are provided as a
Source Data file.
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the mutants can thus be easily tested by a viability assay. We
found that all yeast variants, except K594E, were able to activate
v-Src (Fig. 4b). In contrast, yeast carrying the human Hsp90ß-
WT and the respective human mutants were not able to fully
activate v-Src, as cell growth was still detectable. The results for
hHsp90β are in agreement with previous data, where yeast,
expressing hHsp90β, were shown to be less sensitive to the
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Fig. 4 Changes at the position of the conserved lysine affect client activation. a Yeast strains were exposed to the indicated dosage of UV light and
subsequently analyzed for their ability to induce the Hsp90 dependent nucleotide excision repair. b The activation of the Hsp90 client v-src was tested by a
lethality assay. Survival implies the inability of Hsp90 to activate v-src. c The activity of the glucocorticoid receptor (GR), which is dependent on Hsp90
was measured in a ß-galactosidase assay. Activities were normalized to ß-galactosidase activity of wt Hsp90. The error bars for the activity represent s.d.
from three biological replicates (n= 3). Statistical significance was assessed using a two-sample t-test and a level of significance of 0.05 (*), 0.01 (**), and
0.001 (***). d The binding of the different Hsp90 constructs to the ligand binding domain of the glucocorticoid receptor (GR-LBD) was analyzed by
analytical ultracentrifugation. dc/dt plots are shown for GR-LBD-Atto 488 (purple) and the mixtures of GR-LBDm-Atto 488 with the indicated Hsp90
mutants. Source data are provided as a Source Data file.
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We next assayed the activity of another stringent client of
Hsp90, the glucocorticoid receptor (GR) in the presence of the
Hsp90 mutants, using a β-galactosidase-based reporter assay63,69
(Fig. 4c). We observed an activity pattern for the different
mutants comparable to that obtained in the assays above. The
substitution of the lysine to the arginine (K594R/K607R) resulted
in a WT-like activation of the GR. The substitution to glutamate
(K594E) exhibited an 80% reduction of GR activation, while the
substitutions to alanine and isoleucine (K594A/K607A and
K594I/K607I) lead to a decrease in the activation of about 50%.
For human Hsp90β, the activation of GR by K607I was slightly
more decreased.
Taken together, changes at the position of the conserved lysine
affect client processing in the living cell and are thus crucial for
the biological function of Hsp90.
In addition, aUC experiments were performed using the
purified GR-LBD as a client in vitro (Fig. 4d). The results show
an impaired binding of the GR-LBD to the respective Hsp90
mutants with K594E and K607E exhibiting the strongest effects.
The results are in line with the in vivo data and demonstrate the
importance of lysine 594/607 on regulating client interaction.
Molecular dynamics simulations of Hsp90 variants. To probe
how PTMs and residue substitutions at the position of the con-
served lysine influence the dynamics of Hsp90, we performed
atomistic molecular dynamics (MD) simulations of the mono-
methylated Lys-594 (K594metK), as well as for the in silico
mutated K594R/E/I/A constructs and compared them with the
dynamics of yHsp90-WT. All models were constructed based on
the X-ray structure of the full-length yeast Hsp90 dimer (PDB ID:
2CG9)15. We observed that in the simulations with a methylated
Lys-594, the distance between a pair of helices of the CTDs
decreases in comparison to WT-Hsp90 (Fig. 5a, b) and the
number of salt bridges between the two domains is slightly
increased (Supplementary Fig. 6A–F). Interestingly, the dimeric
pair of helix-1 in the CTD, which forms a putative dimerization
interface in Hsp9015, moves closer together and causes con-
formational changes in the surrounding charged residues (Fig. 5a,
b). For the non-methylated WT-Hsp90 model, Lys-594 strongly
interacts with Glu-590 and Asp-659, whereas the methylation
increases the distance between these residues (Fig. 5a, b). This in
turn enhances the interaction between Glu-590 and Arg-591, thus
increasing the inter-subunit contacts (Fig. 5c; Supplementary
Fig. 6A, B). When Lys-594 is modelled in its methylated state,
Arg-591 takes the position of the lysine sidechain, which in turn
results in more closely packed helices at the dimerization inter-
face. Moreover, Arg-599 and Asp-600, which are located in the
loop following helix 1 with the methylated Lys-594, make con-
tacts with Glu-431 and Lys-335 from the middle domains, leading
to the formation of two new salt bridges between the CTD and
the middle domains (Supplementary Fig. 7)
In order to identify if the studied single point substitutions,
K594R/E/I/A, resemble the effect of the methylated Lys-594, we
performed atomistic MD simulations on the in silico mutated
constructs and analyzed their ion-pair dynamics (Fig. 5c). We
found that in WT-Hsp90 simulations, the Glu-590/Arg-591 ion
pair remains open, whereas the methylation triggers several
closing transitions in this ion pair, indicating that the PTM
modifies the free energy landscape of the dimerization interface.
Interestingly, we found that in simulations of the K594I, the
Glu-590/Arg-591 also flickers between open and closed states,
suggesting that K594I could mimic, at least in part, the effect of
Lys-594 methylation.
Although the simulation timescale is here limited to a few
hundred nanoseconds due to the large size of the protein, our
analysis of ion-pair dynamics and inter-domain salt bridges
indicates that the methylation or mutation of Lys-594 may also
affect the conformational dynamics in the global Hsp90 structure
(Supplementary Figs. 6A–F and 8A–D). The K594I model shows in
addition to an increase in ion pairs between the CTDs, also a slight
increase in salt bridges between the two middle domains
(Supplementary Fig. 6A–F). Moreover, we found that the dynamics
of the helices at the dimerization interface resemble each other in
the methylated lysine and K594I models (Supplementary Fig. 9),
further supporting that K594I could mimic the effect of Lys-594
methylation. Interestingly, all Lys-594 substitutions show a small
decrease in the ion pairs between the two NTDs as compared with
WT-Hsp90 (Supplementary Fig. 6A–F). For example, the MD
simulation of the WT protein shows a strong intermolecular ion
pair between Glu-11 and Lys-102 of the two NTDs that is absent in
the monomethylated variant, indicating some conformational
changes that could propagate across the Hsp90 dimer (Supplemen-
tary Fig. 7). These findings are consistent with our previous
experiments showing that modifications at this position have a
significant influence on NTD dimerization and therefore serve as
an allosteric regulation point in Hsp90. Moreover, some global
conformational changes in the dynamics are also supported by
analysis of backbone root-mean-square deviations (RMSD) (Sup-
plementary Fig. 10). Importantly, although the primary events
leading to the global dynamical changes in Hsp90 are probably
captured during the MD trajectories, the overall simulation
timescales is, nevertheless, too short to accurately probe the global
conformational changes in Hsp90 structure. Overall, however, our
MD simulations suggest that methylation of Lys-594 influences the
C-terminal domain by affecting electrostatic interactions amongst
charged residues. The combined electrostatic-conformational effect
may propagate further to the middle- and N-terminal domain,
supporting the putative role of Lys-594 as an important switch
point in Hsp90.
Replacement of the lysine causes structural changes in Hsp90.
To directly test the effect of lysine methylation, we set out to
introduce a mono-methylated lysine at position 594 in yeast Hsp90
via amber suppression (K594metK) using orthogonal Methano-
sarcina barkeri pyrrolysyl tRNA synthetase (PylRS)/tRNA pairs
(Supplementary Fig. 11A). We screened different PylRS mutants
for efficient and site-specific incorporation of Nε-methyl-Nε(p-
nitrocarbobenzyloxy)lysine (met-ncbK) into proteins bearing a
prematurely introduced amber codon (Supplementary Fig. 11B).
A recently discovered PylRS variant showed efficient production of
full-length proteins and site-specific and quantitative incorporation
of Met-Lys (metK), determined via LC–MS (Supplementary
Fig. 11B). We were able to express and purify mono-methylated
Hsp90 (Supplementary Fig. 11C). MS analysis revealed a 30%
incorporation of metK resulting in a distribution of WT/WT (0.7 ×
0.7= 0.49), WT/K594metK (0.3 × 0.7 × 2= 0.42), and K594metK/
K594metK (0.3 × 0.3= 0.09) dimer formation resulting in a total of
51% methylated species. For fluorescence resonance energy transfer
(FRET) experiments, we labelled the three mutants (K594I, K594E,
K594metK) at specific sites in the N-domains with donor and
acceptor dyes and analyzed their conformational changes16. In the
presence of nucleotides, the WT Hsp90 as well as the K594I, K594E,
and K594metK mutants showed an increase in the acceptor fluor-
escence, which is indicative of the formation of a closed state.
However, we found that the kinetics and amplitudes of the closing
process are significantly decreased for the mutants, with K594E
having the strongest effect (Fig. 6a, b). The addition of the non-
hydrolyzable ATP analogue, AMP-PNP, gave an even stronger
effect. Interestingly, the K594metK mutant showed similarities in
regards of a decline in the amplitude as well as a slower closing,
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compared with K594I upon ATPγS addition. We found that the
kinetics of N-terminal dimerization are significantly impaired
compared with the WT (Fig. 6c). The lack of closed conformations
is in agreement with the lowered ATPase activity, the defect in p23/
Sba1 binding, and the somewhat lowered number of salt bridges
formed between the NTDs in the MD simulations. We next tested
the stability of the dimeric complex in the presence of various
nucleotides, which reports on the presence of N-terminally closed
states (Fig. 6d). To this end, an excess of unlabelled protein was
added to a preformed FRET-hetero complex. In the absence of
nucleotides and in the presence of ATP, for the WT as well as the
K594E and K594I mutants, FRET dimers could be rapidly dis-
sociated by the excess of unlabelled protein. This effect arises from
the open conformation of the FRET-hetero complexes in which
subunit exchange can rapidly occur16,70. In the presence of ATPγS,
a disruption of the WT and mutant complexes was also observed,
but for K594E and K594I, the dissociation was significantly faster,
which is consistent with the slower closing kinetics (Fig. 6a). The
largest differences were monitored in the presence of AMP-PNP.
For K594E, a rapid dissociation of the complex was observed
after addition of unlabelled Hsp90. For K594I, the dissociation was
slightly slower, whereas the WT remained in its closed conforma-
tion. These results support the notion that the N-terminal dimer-
ization is impaired in the mutants.
In addition to the FRET experiments, we also performed
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Fig. 5 Molecular dynamics simulations of the Hsp90 variants. a, b Snapshots obtained from 200 ns MD simulation of the wild type (WT) and mono-
methylated Lys-594 model (metK594). ATP, located in the N-domain, is shown in van-der-Waals (vdW) representation (in yellow). The constitutive interface
of the two C-domains comprises three pairs of helices, with K594/metK594 located on Helix 1 shown in vdW representation (in red). The figure shows the
distance between the centres of mass of three pairs of helices from the two CTDs. c The distance and probability distribution (occurrence, %) of the E590-R591
(Cδ-Cζ) ion pair in MD simulations. Open (r > 5Å) and closed (r < 5Å) conformations of the ion pair are marked with a dashed line. In WT Hsp90, the ion pair
remains open in both Hsp90 protomers (chains 1 and 2), whereas the ion pair undergoes several closing transitions upon methylation. In terms of these ion-pair
dynamics, the K594I simulation resembles the methylated Lys-594 simulation, with a few closure events observed during the trajectory.
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in the presence and absence of nucleotides (Fig. 6e). In these
experiments, a shift towards higher S values corresponds to a
more compact conformation of the Hsp90 dimer. For the WT
protein, we observed a shift towards higher S values in the
presence of ATPγS or AMP-PNP, whereas the K594I mutant
showed significantly lower S values (Supplementary Table 1).
Furthermore, the K594E mutant did not exhibit a detectable
shift, neither in the presence of ATPγS nor AMP-PNP. These
results are in line with the closing kinetics (Fig. 6a) and chasing
kinetics (Fig. 6d) determined by FRET, demonstrating a defect
in the N-terminal dimerization of both mutants, with K594E
showing a more pronounced effect.
Discussion
The eukaryotic Hsp90 is subjected to various PTMs. Some tran-
sient modifications regulate the association or dissociation of
co-chaperones as well as client protein maturation28,30,33,35.
However, the effect of the recently discovered methylation of
Hsp90 by the lysine methyltransferase Smyd239,40, which is
required for muscle stability40,41, has remained elusive. We set
out to analyze the effect of variations at this conserved lysine
position in vitro and in vivo and found that the site functions as
an allosteric regulation point in Hsp90.
The exchange of the lysine by amino acids differing in size,
hydrophobicity, and charge caused pronounced effects in Hsp90.
Especially the introduction of a negative charge resulted in
functional consequences in distinct parts of the protein. Strik-
ingly, the intrinsic ATP turnover of Hsp90 was affected. This is
interesting as the site is located in the CTD and ~70 Å away from
the ATP binding site in the NTD and the catalytic loop in the M-
domain. There are two major ways in which PTMs can change
the function of a protein, either via a direct mechanism at the site
of the modification or by changing the protein conformation. In
the latter, the effects are allosteric as part of the protein far away
from the modified amino acid is influenced71. We refer to these





































































































































































































Fig. 6 Comparison of the conformational rearrangements in the Hsp90 variants. a The nucleotide-induced closure of the FRET pair labelled dimer was
monitored in the acceptor channel after addition of the different nucleotides. b ATPγS induced closing kinetics of mono-methylated Hsp90 (K594metK)
and WT yeast Hsp90. c Closing kinetics of three independent measurements. Data were fitted using a bi-exponential fit (see methods Eq. 1). The error bars
for the turnover rates represent s.d. (n= 3). Statistical significance was assessed using a two-sample t-test and a level of significance of 0.05 (*), 0.01 (**),
and 0.001 (***). d The disruption of a preformed FRET complex was followed after adding an excess of unlabelled protein. Left panel shows the kinetics for
the WT and the middle and right panel for the K594I and K594E mutants. e Sedimentation profiles of the labelled WT, K594I, and K594E mutants in the
absence and presence of the nucleotides ATPγS and AMP-PNP. Source data are provided as a Source Data file.
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-15048-8 ARTICLE
NATURE COMMUNICATIONS |         (2020) 11:1219 | https://doi.org/10.1038/s41467-020-15048-8 | www.nature.com/naturecommunications 9
specific amino acids as “switch points” as these respond to small
changes and have a huge impact on the overall conformation and
function of the protein. These sites are often targeted by PTMs.
All studied single point mutants, except for the lysine to
arginine substitution, resulted in an impaired ATPase activity.
Comparing the replacement by sidechains of different character,
negative charges revealed the most severe effects. It was recently
suggested by MD simulations that ATPase-inhibiting allosteric
regulation points rigidify the movements of the N- and M-
domains, thereby decelerating the formation of the hydrolysis-
competent, closed state72. The same could be envisioned for these
mutants. In the case of the negative charge replacement, our
FRET and aUC data show that the formation of the N-terminally
closed state is impaired. Accordingly, the conformation-sensitive
co-chaperone p23/Sba1, a known sensor of the N-terminally
closed state51,54,56, exhibited decreased binding to the neutral and
reverse charge mutants compared with the WT. Interestingly, the
co-chaperone Aha1, which accelerates the formation of the closed
state in the WT protein13,50, could not influence the kinetics and
thus was not able to overcome the conformational restrictions
caused by the amino acid replacements. Since Aha1 binds to the
M- and N-domains of Hsp90, a direct effect on its binding can be
excluded. With regards to client protein binding, the ligand
binding domain of the GR (GR-LBD), which is known to bind to
the closed conformation of Hsp9073, showed a decreased affinity
for the neutral and positively charged substitutions.
The open state however seems not to be influenced by any
of the tested mutations, as we showed that the binding of the co-
chaperone Sti1, which is known to bind to Hsp90 when adopting
an open conformation is unchanged19,53. Further, aUC experi-
ments demonstrate no changes in sedimentation in the absence of
nucleotide.
The defects in forming N-terminally closed states and the
concomitant changes in timing of specific steps of the con-
formational cycle translate into function defects in client inter-
action and activation as shown in vivo and in vitro. Thus,
modulation of this residue by PTM seems to allow fine-tuning of
Hsp90 towards client processing.
In contrast to functionally important amino acids, PTM posi-
tions are generally not conserved23,28. There are some positions
that cannot be found in different organisms, while others seem to
be more conserved. In the case of the methylation positions, a
highly conserved structural element is targeted. This high invar-
iance is also reflected in the identical effects of the amino acid
substitutions in the yeast and the human proteins. The analysis of
both proteins in parallel showed that they react identically to the
changes at the position of the methylated lysine. This is in
agreement with previous studies which showed that the basic
principles of Hsp90 function are conserved74,75. Replacing the
lysine by neutral amino acids such as alanine or isoleucine
resulted in similar effects in yeast and human Hsp90 in all tested
assays. Both substitutions decreased the ATPase activity to about
50% of the WT activity, and led to an impaired interaction with
the co-chaperones p23/Sba1 and Aha1 as well as the GR-LBD.
Also, the reverse charge replacements to a glutamic acid had a
severe effect in both the yeast and human proteins. Notably,
the effect of the glutamate substitutions on the conformation of
the mutants was so pronounced that Aha1 could not impact the
ATPase activity, although its binding was not inhibited.
At a first glance, the results in S. cerevisiae seem to differ
between the yeast and human proteins, but this effect could arise
from an ineffective replacement of the human Hsp90 by the
authentic protein in S. cerevisiae, and hence the yeast cells
reacted more sensitively to the replacement in the human pro-
tein. Nevertheless, the general effects of the replacement
mutants remained similar. While yeast cells carrying K607E
were not viable, the K594E cells were most sensitive in all stress
assays tested. The neutral replacement mutants of human Hsp90
were sensitive to mild stressors like temperature changes, while
their yeast homologues required more severe stressors like
radicicol to induce similar effects, and similar effects were also
observed in the client maturation assays. Based on our func-
tional analysis we speculate that a symetrical methylation of
both protomers might be possible since methylation induces a
shift to the open conformation, which could further facilitate the
accessibility of SMYD2.
There are two known phosphorylation sites in yeast Hsp90
(S602 and S604)28 that are in proximity to K594. However, the
effects of each modification is distinct: The phosphomimetic
mutant S604E influences yeast growth but has no impact on N-
terminal association, whereas S602E neither affects yeast viabi-
lity nor N-terminal dimerization28. In human Hsp90, there are
three known phosphorylation sites in proximity to K607/615.
Further, K607/615 is also subject to acetylation and ubiquiti-
nation76, demonstrating that this region is a hot spot for reg-
ulation by PTMs. We therefore speculate that this area serves as
a general regulation site, allowing the fine tuning of Hsp90 for
specific needs.
Atomistic molecular dynamics (MD) simulations of WT and
methylated Lys-594 variant of Hsp90 suggest that the lysine
methylation introduces specific conformational changes in the
protein structure. We observed that the bulkier sidechain of the
methylated Lys-594 leads to a decrease in the distance between
two CTDs in comparison to WT Hsp90, an effect that also pro-
pagated to the M-large domain. We could track some of these
effects to specific ion-pair dynamics, e.g. to the Glu-590/Arg-591
ion pair, which is perturbed due to methylation. Moreover, we
identified a change in the specific interactions of the N- and M-
domains and could hence show a propagation of information
from the C- to the N-terminus. To this end, our simulations of
the K594I variant showed similar behaviour as the methylated
Lys-594 variant of Hsp90, suggesting that the K594I variant
might resemble the effect of lysine methylation. We therefore
think that the effects we saw for the K594I mutant in vitro
and in vivo represent those induced by the methylation of lysine
594/607. Our findings additionally imply that the substitution to
an isoleucine might be able to mimic the effects of a mono-
methylated lysine in general. Overall, our MD simulations
suggested that Lys-594 methylation perturbs both intra- and
inter-molecular electrostatic interactions between charged resi-
dues in the CTD, the middle domain, and with some effects also
visible in the NTD, supporting that Lys-594 has an important role
as a switch point in Hsp90. There are other known switch points
in Hsp90. Retzlaff et al. discovered that substitutions at C597
(human Hsp90) or A577 (yeast Hsp90) both affect C-terminal as
well as N-terminal dimerization33. In human Hsp90, C597 is
thought to be nitrosylated by the endothelial nitric oxide syn-
thase, which is regulated by Hsp9077. Rutz et al. showed that
mutations at position W312 (human Hsp90)/W300 (yeast Hsp90)
resulted in a more closed conformation of Hsp90 with an
increased ATPase activity and a deficiency to maturate the GR78.
In this work, a switch point was identified, which affects
N-terminal dimerization, and ATPase activity.
We speculate that the respective switch points may have
specific effects on different clients and adjust Hsp90 in a certain
way. A cross talk of the Hsp90 switch points might add another
layer to the regulation.
There are different models to explain our results. Hsp90 cycles
through energetically equivalent conformations. The binding of
nucleotides shifts this equilibrium towards the N-terminally
closed state. The methylation of K594/607 might cause local
changes, which selectively stabilize the open conformation of
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Hsp90. This model of differential stabilization has been described
previously in the context of different proteins79–81. In the case
of Hsp90 methylation at K594/607 it can explain our findings
regarding the closing defects, ATPase impairment, and defi-
ciencies in the binding of co-chaperones and clients, which favour
the closed conformation of Hsp90. Interestingly, however, the co-
chaperone Sti1 did not show any changes in inhibiting the
ATPase activity of the different variants. Further, AUC experi-
ments of the K594I and K594E mutants showed no changes in
their S values in the absence of nucleotides, but a shift to lower S
values was detected in the presence of nucleotides compared with
the WT. These results indicate that methylation at position K594/
607 does not stabilize a specific Hsp90 conformation per se but
inhibits the proper closing upon nucleotide binding. The MD
simulations further suggest that the methylation affects residues
in the vicinity of the modification but also in distant parts of
the protein. Thus, in our view, these findings can be best
explained assuming a network of inter-domain conformational
communication, which is affected by methylation of K594/607.
This network involves residues in the C-domain which transfer
the information to parts of the M- and probably N-domain
responsible for the formation of the closed state upon nucleotide
binding14,28,33,70,72,82
Hsp90 is important for the maturation and regulation of a large
number of client proteins, which do often differ in their function,
structure, and interaction with Hsp901–8,83. Co-chaperones and
post-translational modifications can shape the landscape of these
interactions in favour of a specific client protein, allowing regulation
of proteostasis in a context-specific manner19,20,23,28,33. The muscle
protein titin whose interaction with the Hsp90 machinery is affected
by methylation, is an example in case, leading to a regulated
arrangement of the muscle architecture40,41. Interestingly, in vivo
studies suggested an enhanced binding of the muscle protein titin,
while in our study we showed a deficit in binding the GR. We
hypothesize that titin might prefer an open conformation of Hsp90
for proper interaction as it was shown for other clients84. The
methylation of smyd2 might therefore enable Hsp90 to distinguish
between different clients. The changes in Hsp90 dynamics and
interaction pattern with co-chaperones or clients upon regulated
changes in lysine 594/607 thus serve to adapt the chaperone to
specific requirements and connects it to cellular signalling.
Methods
Site-specific incorporation of met-ncbK. Met-ncbK (N6-methyl-N6-(((4-nitro-
benzyl)oxy)carbonyl)-L-lysine) was purchased from AF ChemPharm at >97%
purity. The aminoacyl-tRNA synthetase (aaRS), which site specifically incorporates
met-ncbK, was found after screening ~100 aaRS mutants available in the lab. If cells
carried an aaRS mutant, which lead to amber suppression, sfGFP(N150TAG)-His6
was purified. First, the cells were lysed in 10mL GFP wash buffer (20mM Tris-HCl
pH 8, 300mM NaCl, 30mM imidazole) per 1 g pellet using the Branson Ultra-
sonics™ Sonifier™ SFX250/SFX550 Cell Disruptor (20% intensity, 50% pulse, 5 min).
After the lysate was cleared (14,000 × g, 15 min, 4 °C) the supernatant was incubated
with 200 µL Ni2+-NTA beads (Jena Bioscience) per 1 g cell pellet for 1 h at 4 °C.
Finally, the beads were washed three times with GFP wash buffer before the protein
was eluted twice with 1 mL GFP elution buffer (20mM Tris-HCl pH 8, 300mM
NaCl, 300mM imidazole). The incorporation and decaging of the UAA was con-
firmed using LC–MS and SDS-PAGE. The positive hit will further be dubbed as
metK-RS. This aaRS also incorporates several other unnatural amino acids85,86.
Protein expression and purification of metK bearing proteins. The proteins
sfGFP(N150TAG)-His6, myoglobine(S4TAG)-His6, Rab1b(Q76A, R79TAG)-His6,
and GFP-nanobody (R18TAG)-His6 were expressed overnight at 37 °C in 2xYT
with the respective antibiotics. At OD 0.6–0.7, protein expression was induced
using 0.02% (w/v) arabinose. The medium was further complemented with 1 mM
met-ncbK.85
sfGFP and myoglobine were purified as described above. GFP-nanobody was
also purified as described above using the respective wash and elution buffers
(nanobody wash buffer: 1× PBS, 500 mM NaCl, 30 mM imidazole, 2 mM PMSF;
nanobody elution buffer: 1× PBS, 500 mM NaCl, 300 mM imidazole). The same
purification protocol was used for Rab1b, although the respective wash buffer was
complemented with 0.2 mM PMSF, 0.01 mM GDP, cOmplete protease inhibitor
cocktail tablets (Roche) for cell lysis (Rab1b wash buffer: 40 mM HEPES pH 8,
2 mM ß-ME, 1 mM MgCl2, 500 mM LiCl, 0.01 mM GDP, 20 mM imidazole; Rab1b
elution buffer: 40 mM HEPES pH 8, 2 mM ß-ME, 1 mM MgCl2, 500 mM LiCl,
0.01 mM GDP, 300 mM imidazole).85,87
The incorporation of met-ncbK and quantitative decaging to metK was
confirmed using full-length ESI-LC MS (Phenomenex JupiterTM C4 column (2 ×
150 mm, 5 μm)) and carried out on an Agilent Technologies 1260 Infinity LC–MS
system with a 6310 quadrupole spectrometer. Buffer A was 0.1% formic acid in
water; buffer B was 0.1% formic acid in acetonitrile.
Protein expression and purification. All yeast and human mutations were
introduced by site-directed mutagenesis in pET28 vectors (Invitrogen, Karlsruhe,
Germany) containing the yeast (Hsp82) or human sequence of Hsp90 (Hsp90β)
(Supplementary Table 2). For amber suppression, the Hsp90 sequence was intro-
duced into a pPylT vector, encoding for the orthogonal PylT-tRNA85. The plas-
mids were transformed into BL21 (DE3) cod+ (Stratagene, La Jolla, USA) and
proteins were expressed for 4 h at 37 °C (yeast) or overnight at 20 °C (human).
Cells were lysed using a cell disruption system (Constant Systems, Warwick, UK).
After lysate clarification, the supernatant was loaded on a 5 mL HisTrap HP col-
umn (GE Healthcare), equilibrated with Ni-NTA buffer A (40 mM KPO4, pH 8.0,
400 mM KCl, 6 mM imidazole). After washing the column with washing buffer
(40 mM KPO4, pH 8.0, 400 mM KCl, 20 mM imidazole), the protein was eluted
with Ni-NTA buffer B (40 mM KPO4, pH 8.0, 400 mM KCl, 300 mM imidazole).
Fractions were pooled and diluted with Resource Q buffer A (50 mM Tris, pH 8.0,
20 mM KCl) and loaded on a 6 mL Resource Q column (GE Healthcare). Proteins
were eluted with a gradient, using Resource Q buffer B (50 mM Tris, pH 8.0,
1000 mM KCl). A Superdex 16/60 200 pg column (GE Healthcare) was used for the
last purification step, equilibrated with 40 mM HEPES, pH 7.5, 150 mM KCl, 5 mM
MgCl2. For the human proteins and the Hsp82 D61C variant, 1 mM DTT was
added to each buffer. For Aha1, protein expression was conducted over night at
18 °C. After the Ni-NTA (buffer A: 50 mM NaHPO4, pH 7.8, 300 mM NaCl,
20 mM imidazole; buffer B: 50 mM NaHPO4, pH 7.8, 300 mM NaCl, 300 mM
imidazole), fractions were pooled and loaded directly on the Superdex column. The
GR-LBD was expressed and purified according to Lorenz et al.73. Expression was
conducted over night at 18 °C in ZYM-5052 media, supplemented with 500 µM
dexamethasone (Sigma Aldrich). After cells were harvested, a PBS wash was
applied and cells were lysed via sonication (Bandelin Sonopuls UW2200) in
Ni-NTA buffer A (50 mM Tris, pH 7.9, 2 M Urea, 100 mM NaCl, 5 mM MgCl2,
10 mM imidazole, 2 mM β-mercaptoethanol, 50 µM dexamethasone). After clear-
ance, the lysate was loaded on a 5 mL HisTrap HP column, equilibrated with
Ni-NTA buffer B (50 mM Tris, pH 7.9, 500 mM NaCl, 10 mM imidazole, 2 mM
β-mercaptoethanol, 10% glycerol, 50 µM dexamethasone). Proteins were eluted
with Ni-NTA buffer C (50 mM Tris, pH 7.9, 500 mM NaCl, 350 mM imidazole,
2 mM β-mercaptoethanol, 10% glycerol, 50 µM dexamethasone). Fractions were
pooled, supplemented with His6-tagged TEV-protease, and dialyzed against 50 mM
Tris, pH 7.9, 100 mM NaCl, 10% glycerol, 2 mM β-mercaptoethanol, 0.5% CHAPS,
50 µM dexamethasone over night at 4 °C. The digested protein was loaded on a
HisTrap HP column and the flowthrough was collected. The protein was con-
centrated and loaded on a Superdex 16/60 200 pg column equilibrated in 25 mM
Tris, pH 7.9, 100 mM NaCl, 10% glycerol, 2 mM DTT, 50 µM dexamethasone.
For the incorporation of met-ncbK, the pPylT plasmid carrying the tRNA and
the Hsp82_D61C gene with an N-terminal GST- and C-terminal His-tag were co-
transformed with the pBK plasmid carrying the respective PylRS88 into E. coli K12.
Cells were grown in 2xYT (10 µg/mL tetracycline, 100 µg/mL ampicillin). At an
OD600 of 0.6, 1 mM of the met-ncbK was added. At an OD600 of 0.8, protein
expression was induced with 0.02% arabinose (4 h, 37 °C). Cells were harvested and
resuspended in Ni-NTA buffer A (50 mM NaH2PO4, 500 mM NaCl, 10 mM
imidazole, 1 mM DTT, pH 7.8) supplemented with EDTA-free protease inhibitor
(SERVA) and DNase1. Cells were lysed using a cell disruption system (Constant
Systems) at 1.8 kbar. After lysate clarification, the supernatant was loaded on a
5 mL HisTrap HP column (GE Healthcare), washed with 10 CV Ni-NTA buffer
A and 10 CV 5% Ni-NTA buffer B (50 mM NaH2PO4, 500 mM NaCl, 300 mM
imidazole, 1 mM DTT, pH 7.8). The bound proteins were eluted with 100% Ni-
NTA buffer B. Fractions were diluted 1:10 with PBS (16 mM Na2HPO4, 4 mM
KH2PO4 115 mM NaCl, 2.7 mM KCL, pH 7.4) and loaded on a 5 mL GSTrap HP
column (GE Healthcare), washed with 10 CV PBS, and eluted with GST buffer B
(50 mM Tris, 20 mM reduced glutathione, pH 8.0). Fractions were incubated with
TEV-protease ON at 4 °C. The solution was loaded on a Superdex 16/60 200 pg
SEC column (GE Healthcare) and eluted with SEC buffer (40 mM HEPES, 150 mM
KCl, 5 mM MgCl2).
To identify the incorporation efficiency of metK into Hsp82, Asp-N protease
from Pseudomonas fragi (Promega) was used for digestion, prior to MALDI-MS
analysis. The protein was digested according to the manufacturer’s protocol and
MS analysis was conducted using a Biflex-II mass spectrometer (Bruker Daltonik,
Bremen, Germany). Data were analysed using Mascot (Matrix Science,
London, UK).
Protein secondary structure. To determine the secondary structure of the purified
mutants, Far-UV CD-spectra were measured. Proteins were dialyzed in 5 mM
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NaPO4 (pH 7.5) and a concentration of 0.2 mg/mL was used. CD-spectra were
collected between 190 nm and 260 nm in a J-710 spectropolarimeter at 20 °C.
ATPase assays. ATPase assays were performed by a spectrophotometric assay
using an enzymatic ATP regenerating system89. 10 μM of human Hsp90 and 3 μM
of yeast Hsp90 were used in 40 mM Hepes (pH 7.5), 150 mM KCl, 5 mM MgCl2.
Measurements were performed at 30 °C for the yeast proteins and at 37 °C for the
human homologues. To substract the background activity, 100 μM radicicol
(Sigma, Germany) were added at the end of the measurement. The data were
analyzed by linear regression using Origin 8.0 and for ATP-binding, data were
fitted according to the Michaelis–Menten equation. For the activation by Aha1, a
low salt assay buffer (40 mM Hepes (pH 7.5), 20 mM KCl, 5 mM MgCl2) was used,
as the affinity between Hsp90 and Aha1 is salt sensitive57.
Analytical ultracentrifugation (aUC). To analyze the ability to form complexes
with co-chaperones and clients and to determine structural changes, the Hsp90
mutants were subjected to aUC (Beckman, Krefeld, Germany). 0.5 μM of labelled
co-chaperones (Aha1-FAM and Sba1-Atto488) were incubated in the absence (for
Aha1 interaction) or presence of 2 mM AMP-PNP (for Sba1 interaction) with 3 μM
of the respective Hsp90 mutants. Buffers were 40 mM Hepes (pH 7.5), 20 mM KCl,
5 mM MgCl2 for the Aha1 interaction and 40 mM Hepes (pH 7.5), 150 mM KCl,
5 mM MgCl2 for the Sba1 interaction. The buffer for human Hsp90 additionally
contained 2 mM DTT. To analyze the interaction with the GR, 0.5 μM of Atto488-
labelled GR-LBDm were used in 20 mM Hepes (pH 7.5), 20 mM KCl, 5 mMMgCl2,
5 mM DTT and 2 mM ATP. For the experiments with yeast Hsp90 alone, 2 µM of
Atto488-labelled Hsp82 in 40 mM Hepes (pH 7.5), 150 mM KCl, 5 mM MgCl2,
incubated in the absence or presence of 5 mM AMP-PNP or 5 mM ATPγS were
used. Runs were performed at 42,000 rpm, 20 °C and complex formation was
monitored using an Avis Fluorescence detection system (Lakewood, USA). The raw
data were converted into a dc/dt plot using SEDVIEW and curves were fitted by
Gaussian equations.
Yeast methods and FOA shuffling. The yeast strain ECU82α62, whose only copy
of Hsp90 is on an URA3-containg pKAT6 plasmid, was used throughout this study
and standard methods for growth and transformations were employed. Cells were
cultured on selective minimal medium (0.67% yeast nitrogen base, 2% glucose and
amino acids depending on auxotrophy) at 30 °C. To examine the ability of the
human and yeast mutants to confer viability, constructs were subcloned into
p423GPD vectors (ATCC90) and transformed into ECU82α. By a plasmid shuffling
approach using 5-FOA, the pKAT6 plasmid was replaced with the yeast and
human mutants, as the sole source of Hsp90 in the cell91.
Yeast stress assays. To test the influence of the mutants, cells were challenged
either by heat, UV irradiation, or the Hsp90 inhibitor radicicol. To investigate
temperature effects, overnight cultures were adjusted to an OD600 of 0.5 and
1:5 dilutions were spotted on selective agar plates. Cells were incubated at the
indicated temperatures for 48 h. To test the influence of Hsp90 in nucleotide
excision repair, cells were spotted as described and plates were exposed to UV light
(40 J/m2, 80 J/m2, or 120 J/m2) at room temperature and afterwards incubated for
48 h at 30 °C28,67. For the radicicol assay, overnight cultures were adjusted to an
OD600 of 0.1 and the indicated amount of radicicol was added. Cells were grown
overnight in the presence of the inhibitor at 30 °C and then spotted onto selective
agar plates in 1:5 dilutions.
GR activation assay in vivo. A sensitive readout for Hsp90 function in vivo is the
activity of the mammalian GR receptor62. Yeast cells were transformed with a
plasmid constitutively expressing GR. Positive clones were cultivated overnight in
selective medium and diluted into media containing 10 μM desoxycorticosterone
(Sigma, Germany) for ~12 h. As activated GR binds to a response element coupled
to the β-galactosidase gene, the expression of β-galactosidase can be used as an
indirect readout for GR activity. To monitor ß-galactosidase activity, cells were
lysed and ONPG solution was added. The formation of the chromogenic substrate
ortho-nitrophenol was monitored at 405 nm in a plate reader.
v-src kinase assay. For the viral tyrosine kinase v-src, the assay was performed as
previously described62. In short, a plasmid carrying v-src kinase under the indu-
cible Gal promoter was transformed into the yeast cells. After the selection of
positive transformants, cells were grown for 48 h in raffinose-containing medium
before they were adjusted to the same OD and spotted in 1:5 dilutions onto
glucose- and galactose-containing plates. The growth of the yeast was analyzed
after 48 h at 30 °C.
Molecular dynamics simulations. Atomistic molecular dynamics (MD) simula-
tions were employed to study the WT and methylated Lys-594 models of Hsp90, as
well as the in silico mutated variants K594R/E/I/A. The models were constructed
based on the full-length yeast Hsp90 dimer in the closed state with the ATP-Mg2+
complex is obtained from the Protein Data Bank (PDB ID: 2CG9)15, and with
missing loops modelled using MODELLER92. Each protein model was solvated in a
water box with 100 mM NaCl concentration. The molecular systems comprised
~300,000 atoms and were simulated in an NPT ensemble at T= 310 K and p=
101.3 kPa for 200 ns using NAMD93, with a 2 fs integration timestep, and using the
CHARMM27 force field94. Long-range electrostatics was treated using the particle
mesh Ewald approach. RMSD and root-mean-square fluctuations of the protein
backbone atoms were computed to probe simulation convergence and global
Hsp90 dynamics. Visual molecular dynamics95 was used for analysis of the MD
trajectories.
Fluorescence resonance energy transfer (FRET). FRET experiments were car-
ried out, as described previously16. Hsp90 was labelled at position C61 with donor
and acceptor dyes, respectively (ATTO 488 and ATTO-550, ATTO-TEC GmbH).
Measurements were conducted at 30 °C in a Fluoromax 4 spectrometer. Two
hundred nanomolars of labelled Hsp90 was used in 40 mM Hepes (pH 7.5),
150 mM KCl, 5 mM MgCl2, 2 mM DTT in the absence or presence of 2 mM AMP-
PNP, 2 mM ATPγS or 2 mM ATP. The chase experiments were performed with a
tenfold excess (4 µM) of unlabelled protein. Curves were fitted by a mono-
exponential decay equation. For the K594metK variant, a bi-exponential fit was
used taking into account the relative amounts of the methylated species. t1 was set
fixed with the value of the wt protein.
y ¼ 0:49  A1  e xt1ð Þ þ 0:51  A1  e xt2ð Þ þ y0: ð1Þ
Hsp90 dimerization assay. Measurements were conducted at 25 °C in a Shi-
madzu HPLC using a Superdex 200 increase 10/300 GL in 40 mM Hepes (pH 7.5),
150 mM KCl, 5 mM MgCl2, and 2 mM DTT. Concentration of human Hsp90β
varied from 2 nM to 4 µM. Concentration of yeast Hsp90 varied from 16 nM to
2 µM. Dimerization assays were performed similar to Richter et al.43. In short, a
dilution series of each protein variant was applied, using a volume of 200 µL.
Fluorescence was detected via a RF-10Axl detector (Shimadzu) with excitation at
280 nm and emission at 320 nm wavelength. The gain of the photomultiplier was
adopted for the different concentrations over the time course of the measurement.
Data were fitted, using Origin 8.0 via the following equation:
ET ¼ ETmono  ðETmono  ETdimerÞ 
½protein
protein½  þ KDðappÞ
: ð2Þ
ET represents the elution time, ETmono the elution time of the Hsp90 monomeric
species, and ETdimer the elution time of the Hsp90 dimer. For the determination of
the KD, the KD (app) was divided by the dilution factor, which is the quotient of
the theoretical width of the peak at the point of injection (0.2 mL/0.5 mL/min=
0.4 min) and the observed peak width and was about 4 for both Hsp82 and
human Hsp90.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The source data underlying Figs. 1c, 3a–c, 4a–c, and 6c are provided as a Source Data file.
Other data are available from the corresponding author upon reasonable request.
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